A B S T R A C T Prostacyclin (PGI2) synthetic capacity was assayed at the surface of aortas at various intervals after removal of endothelium with a balloon catheter. Results were correlated with morphologic changes in the vessel wall seen by light microscopy, scanning and transmission electron microscopy. To assay PGI2 synthetic capacity, we applied an incubation chamber to the luminal surface of the aortas; after arachidonic acid stimulation we assayed the PGI2 synthesized with a bioassay and radioimmunoassay. PGI2 synthesis in deendothelialized aortas was determined immediately after balloon-catheter injury and at intervals of 1 h and 2, 4, 15, 35, and 70 d. PGI2 synthesis was low at 1 h and increased over time with levels at 35 and 70 d reaching that of normal artery. Scanning and transmission electron microscopy of de-endothelialized areas showed persistent absence of endothelium with formation of a neointima composed of smooth muscle cells. De-endothelialized aorta was covered with adherent platelets shortly after injury, however several days later only a few platelets adhered to the denuded surface.
INTRODUCTION
Endothelial cells form a thromboresistant surface between the circulating blood and the underlying vessel wall. Several mechanisms have been proposed to explain the thromboresistant character of this endothelial surface. These include (a) electrostatic repulsion of blood cells by endothelial cells (1) , (b) synthesis of plasminogen activator (2) (3) (4) (5) , (c) synthesis of an ectoADPase (6) (7) (8) , and (d) synthesis of heparan sulfate (9) (10) (11) . The recent finding that endothelial cells synthesize prostacyclin (PGI2)1 suggests another possible mechanism to explain the lack of platelet reactivity with endothelium (12) (13) (14) .
When endothelium is removed from the aortic wall, platelets immediately adhere to the exposed subendothelium, forming a carpetlike layer covering the entire luminal surface (15) (16) (17) . However, if similar de-endothelialized areas are examined several days after endothelial removal, relatively few platelets adhere to the vascular surface (18, 19) . The acquired thromboresistance of the de-endothelialized aortic wall is particularly interesting in view ofthe fact that endothelium is generally regarded as the only thromboresistant structure of blood vessels. The mechanism underlying the change in platelet reactivity of de-endothelialized aortic wall has not been well investigated.
Experiments reported here were conducted using an incubation chamber to measure the concentration of PGI2 at the luminal surface of aortas at various intervals after endothelial removal. We used this new tech-'Abbreviations used in this paper: PGF,1t, prostaglandin F,.; PGI2, prostacyclin; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
tion, Inc. * 0021-9738/81/03/0735/06 $1.00 nique to test the hypothesis that increased PGI2 production may be one important mechanism contributing to the acquired thromboresistance that develops with time in de-endothelialized aorta.
METHODS
Removal ofendothelium. Endothelium was removed from rabbit aortas by the method of Baumgartner et al. (20) . A 4F thin-walled Fogarty embolectomy-catheter (Edwards Laboratory, Santa Ana, Calif.) was inserted into the right femoral artery of anesthetized rabbits and pushed into the proximal aorta. The balloon was then inflated to a pressure of 450-500 mm Hg and the inflated catheter was pulled through the aorta three times.
Experimental groups. 71 young female adult white New Zealand rabbits weighing 2,500-3,500 g were fed commercial rabbit ration (Purina Rabbit Chow, Ralston Purina Co., St. Louis, Mo.) and water ad lib. Rabbits were randomly divided into two groups. Group I consisted of 13 Preparation of aortic tissue for microscopy. In animals of Group IIB, full-thickness tissue specimens of aorta were dissected at standard sites for SEM and TEM. Tissue specimens for electron microscopy were taken from de-endothelialized blue areas, white zones ofre-endothelialized islands, and from transitions between these zones and areas. (See Results). These tissues were washed in several changes of 0.1 M calcium cacodylate buffer, pH 7, and processed for SEM and TEM as described (21) . Specimens for SEM were viewed in an ETEC autoscan (ETEC Corp., Hayward, Calif.) and those for TEM in a Philips 301 microscope (Philips Electronic Instruments, Mahwah, N. J.).
PGI2 synthesis by rabbit aorta. Two methods were used to assay PGI2 synthetic capacity of the aortic wall. We sampled randomly chosen areas of luminal surface of uninjured or de-endothelialized aortas because extensive sampling in preliminary experiments indicated no regional difference in PGI2 production along the abdominal and thoracic aorta. In the first method de-endothelialized or uninjured portions of aorta were placed between two lucite plates that were held together with two lateral screws (Fig. 1) . The upper lucite plate contained an elliptical hole (6 x 13 mm) that was narrower than the aortic width, and served as an incubation chamber in which the aortic luminal surface formed the chamber base. Leakage of fluid from this chamber was prevented by a rubber washer attached to the bottom of the upper plate.
The possibility of leakage in or out of the incubation chamber was tested in two ways. Evans blue dye placed in the chamber did not diffuse out of the well. PGI2 placed in one of three incubation chambers of a multi-welled lucite plate was not detected in the other two wells. The remaining aorta, outside the chamber, was immersed in cold Hepes buffer. The aortic surface within the incubation chamber was washed with warm Hepes buffer (37°C). Then, to assay PGI2 production, 15 mM Tris prepared in physiologic saline, pH 8.6, containing 27 ,uM arachidonic acid, was warmed to 370C and placed in the incubation chamber for 2 min. The buffer alone did not stimulate PGI2 production during the incubation period; it did preserve PGI2 biological activity because of the alkaline pH. The temperature in the chamber did not fall below 350C during the incubation period. Aortic incubation fluid was then collected, frozen immediately in a dry-ice acetone bath and maintained at -700C until assayed. For comparison, a second assay method was used that employed full-thickness punch biopsies of aortic wall, measuring 6 mm in diameter and weighing -15 mg. These biopsies were incubated at 370C for 2 min in test tubes containing 15 mM Tris-HCl buffer, pH 8.6, plus 27 ,uM arachidonic acid. After incubation, the tissue was removed; the aortic incubation fluid was frozen and stored as described above. To determine if recently de-endothelialized aorta degrades PGI2 to metabolic products other than 6-keto-postaglandin (PG)F1,,, we placed a measured quantity of PGI2 in the incubation chamber on the aorta and measured PGI2 or 6-keto-PGFiat at 2 min. Quantitation ofPGI2. This was performed using our modification of the thrombin-induced serotonin release assay first described by Baenziger et al. (22) . This assay measures inhibition by PGI2 of thrombin-induced ['4C]serotonin release from FIGURE 1 Mechanical drawing of incubation chamber used for PGI2 assay.
prelabeled, washed, aspirin-treated platelets. This assay has been described in detail (13) .
In these experiments, PGI2 synthesis was also assessed by measurement of PGI2 in aortic incubation fluids with a radioimmunoassay for 6-keto-PGF,0. PGI2 in the aortic incubation fluid was converted to 6-keto-PGFi, by acidification to pH 3 with 1 N HCI and/or incubation for 1 h at 37°C. No residual biological activity ofPGI2 remained as tested by the inhibition of platelet aggregation. Antisera against authentic 6-ketoPGFi, conjugated to keyhole limpet hemocyanin were developed in rabbits. Incubation mixtures included lOO,l 3H-6-keto-PGF1,. (10,000 dpm; sp act 100 Ci/mmol, New England Nuclear Corp., Boston, Mass.), 100 ll test sample and 100,ul antiserum at a dilution (1:3200) which bound 50% of the radioactivity in the absence of standard. All dilutions were made using 50 mM Hepes buffer, pH 7.5, containing 0.2% bovine serum albumin. After the mixture was incubated for 18 h at room temperature, the bound radioactivity was separated from residual activity by the addition of Staphylococcus aureus Protein A (Pansorbin, Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) followed by centrifugation at 3,000 g for 30 min. 300 ,lM of supernatant fluid was added to 6 ml Biofluor (New England Nuclear Corp.) and radioactivity was measured (13) . Standard curves were run with each assay using 6-keto-PGF,i,e standards. (Authentic PGI2 and 6-keto-PGF,10 were generous gifts of Dr. John Pike, Upjohn Co., Kalamazoo, Mich.). These were interchangeable with PGI2 standards. This assay had low (<1%) cross-reactivity with other prostaglandins which was similar to other radioimmunoassays reported previously (23) .
Statistical analysis. Aortic-surface PGI2 synthesis in Group I rabbits was compared with synthesis measured in deendothelialized areas of Group IIA rabbits using a single-factor analysis of variance. Inasmuch as testing for homogeneity of variances demonstrated significant differences using Bartlett's test, the data were log transformed (xl = log (x + 1)).
A nonparametric analysis ofvariance (Kruskal-Wallis) was also performed. If significant differences in PGI2 production were detected by analysis of variance using log transformed data, subsequent pair-wise comparisons were performed using Duncan's multiple range test (24, 25) .
Mean quantities of PGI2 produced by aortic punch biopsies from uninjured aortas and de-endothelialized aortas were compared using an independent t test. To prevent bias in the data analyzed, PGI2 synthesis assayed in replicate biopsies or surface incubations of the same aorta were averaged to give a single value for each animal.
Correlation between PGI2 assessed by the thrombininduced serotonin release assay and 6-keto-PGFi, assessed by the radioimmunoassay was tested by the Pearson productmoment correlation analysis (r) (24) .
RESULTS
Macroscopic observations. All rabbits were injected with Evans blue dye. Unballooned aortas of Group I rabbits did not stain. The luminal surface of previously de-endothelialized aortas showed changes similar to those described (21) . A sharp transition was observed between the unballooned segment of the aorta that remained unstained and the more distal segment that had been previously de-endothelialized and stained blue. This latter segment extended from just cephalad to the first intercostal artery to the bifurcation of the abdominal aorta. The entire luminal surface stained blue in aortas of animals de-endothelialized 1 Microscopic observations. As seen with light microscopy, SEM, and TEM, the normal aorta showed intact endothelium and no intimal thickening or adherent platelets (Figs. 2a, b, and c) 48 h after balloon injury revealed that uninjured aortas synthesized 16.5±4.3 ng/ml PGI2 (mean±SEM) in contrast to the de-endothelialized aortas, which synthesized only 1.1±0.7 ng/ml PGI2 (P < 0.001). The mean PGI2 production in aortas ofrabbits de-endothelialized after death was 0.1±0.01 ng/ml. Aortas of these latter animals were washed free of blood by saline perfusion before ballooning and hence there was little or no interaction between cellular elements of the blood and the luminal surface. Results were similar with aortas de-endothelialized by balloon catheter, by collagenase treatment, or by wiping with gauze. The de-endothelialized aortic surface did not degrade PGI2 or 6-keto-PGF1, to other substances. Tissue staining with Evans blue dye did not affect the assay for PGI2. In contrast to the results obtained with the template method, when PGI2 production was assayed in full-thickness punch biopsies of aorta, we were unable to demonstrate any difference in PGI2 synthesis in uninjured aortas of five rabbits as compared with de-endothelialized aortas of four rabbits assayed 48 h after balloon injury. Punch biopsies of uninjured aortas synthesized 8.0±0.4 ng/ml PGI2 and biopsies of de-endothelialized aortas synthesized 7.9± 1.8 ng/ml.
In subsequent experiments, PGI2 production by deendothelialized areas was measured at the aortic luminal surface immediately after balloon-catheter injury and at intervals of 1 h, and 2, 4, 15, 35, and 70 d.
The amounts were 0.1±0.01, 0.3+0.1, 1.1+0.7, 2.7±0.3, 4.9+2±.2 10.3+2.2, and 13.7±3.8 ng/ml, respectively. Thus, as shown in Fig. 3 , PGI2 production was initially low, and increased exponentially with time. PGI2 production at 15 d was significantly increased as compared with 0 time. PGI2 production by the neointima at 35 or 70 d was not significantly different from the normal aorta.
DISCUSSION
We have used a new technique to assay for PGI2 synthesis and release at the luminal surface of normal and de-endothelialized arterial wall. Results of these experiments indicate that as compared with normal artery, (a) PGI2 production is markedly decreased in the recently de-endothelialized aortic wall, (b) smooth muscle cells forming the neointima produce and release increasing quantities of PGI2 onto the luminal surface over time, paralleling the increased thickness ofthe neointima, and (c) recovery of PGI2 synthesis is temporally associated with recovery of thromboresistance by the de-endothelialized aortic wall.
The technique that we have used to assess prostaglandin production by the arterial tissue has several advantages as compared with arterial strips or rings that have been conventionally used (26, 27) . First, this technique is more physiological in that it allows us to assay the activity of prostaglandin at the luminal surface of the vessel wall where these substances affect on the endothelial surface. 1 h after de-endothelialization the endothelium is absent (d) and as seen by TEM and SEM, the wall of the artery is covered by a layer of platelets (e, f). At 35 d after catheter injury there is thickening of the fibromuscular neointima (arrows indicate boundary of intima and media) (g), and the neointima is lined by smooth muscle cells that have protrusions on the luminal surface (h, i). Even though the endothelium is absent, there are no platelets on the surface (h, i). (2a-i; x375, x6000, x2500, x450, x7000, x2500, x750, x5700 and x2600).
platelets and platelet-vessel interactions. The capacity for production of PGI2 with time following injury and during repair of blood vessel walls has been correlated with events at the luminal surface, e.g. platelet-blood vessel interaction. Second, this technique eliminates the contribution of prostaglandins made by smooth muscle cells exposed at the cut edge of specimen (as is the case when rings or strips of arterial tissue were incubated with arachidonic acid). Third, the technique eliminates the possible stimulation of prostaglandin synthesis by acute mechanical injury resulting from punch biopsies or cutting arterial strips or rings (27) . All of these advantages were confirmed by the finding that the present technique was able to differentiate between de-endothelialized aorta and normal aorta, whereas the full-thickness punch-biopsy technique was not.
There was markedly diminished capacity ofthe aortic surface to synthesize PGI2 in animals de-endothelialized 1 and 48 h before killing. Similar findings were seen in aortas of animals that were first perfused with Ringer's solution, killed, and then de-endothelialized to control for (a) an effect of platelet-derived endoperoxides on synthesis of PGI2 by the underlying vascular smooth muscle cells, and (b) inhibition of penetration of arachidonic acid into the vessel wall by the platelet carpet which adheres to the luminal surface of vessels immediately after balloon injury in vivo. Thus, these experiments furnish strong evidence to indicate that in the normal intact artery, the endothelium is responsible for nearly all of the PGI2 released at the luminal surface.
We found, unexpectedly, that the de-endothelialized aorta recovered its capacity to produce PGI2 with time before restoration of a new endothelium, and by d, it had a similar capacity to produce PGI2 onto the luminal surface as did normal artery. Acquisition ofthis capacity correlates with the formation of a neointima of smooth muscle cells (28, 29) and indicates that with time, intimal smooth muscle cells in de-endothelialized aorta synthesize and secrete increased PGI2 into the lumen. This is consistent with the finding that smooth muscle cells tested in vitro possess the capacity to synthesize PGI2 (30) and that enzymes responsible for synthesis of PGI2 are present in-all layers of the vessel wall (31) . Conceivably, this increase in PGI2 production by neointimal smooth muscle cells could result either from increased enzyme activity or from increased access of substrate to smooth muscle cells. Whatever the mechanism, the acquisition of PGI2 production by smooth muscle cells in the vessel wall may have important implications for the response of the arterial wall to injury and subsequent repair.
It is reasonable to suggest that synthesis of PGI2 by intimal smooth muscle cells may contribute significantly to the acquired thromboresistance of the arterial wall since it has been shown previously that PGI2 can prevent adhesion of platelets to the subendothelium in vitro (32) (33) (34) . Moncada et al. (31) suggest that the nonthrombogenicity of the endothelial lining is mainly the result of production of PGI2. Pretreatment of rabbits with high doses of aspirin, which completely blocked PGI2 synthesis in vessels, significantly augmented the size of experimentally induced venous thrombi. A lower dosage of aspirin, which produced less inhibition of PGI2, did not produce this effect. Local instillation of tranylcypromine, an inhibitor of PGI2 synthesis, also significantly augmented thrombus size (35) . However, in in vitro and in vivo systems, Cazenave et al. (36) and Dejana et al. (37) found that aspirin treatment did not promote platelet adherence to the endothelial lining or to subendothelium of the rabbit aorta. Thus conflicting observations exist in different systems as to the function ofPGI2 in thromboresistance. Although the temporal association of increased synthesis of PGI2 with increased thromboresistance of deendothelialized luminal surface suggests a cause and effect relationship, it is not possible to make this conclusion from results of these experiments because the relative contributions of PGI2 and other factors to the thromboresistance of the normal artery and the deendothelialized artery are not known. Definitive in vivo studies will be needed to clarify the relative roles of PGI2 and other factors in the natural and acquired thromboresistance of the normal and abnormal vessel wall.
In conclusion, results of our experiments indicate (a) that endothelium is responsible for nearly all PGI2 production at the luminal surface of the normal artery, and (b) smooth muscle cells in the neointima acquire the ability to produce increasing quantities of PGI2 with time. Findings suggest that this acquisition of PGI2 production by vascular smooth muscle may contribute importantly to the acquired thromboresistance of de-endothelialized aorta.
